Phreesia, Inc.
PHRPhreesia, Inc. is a technology company that provides a cloud-based platform aimed at streamlining patient intake and engagement for healthcare providers. Founded in 2005, the company offers solutions for patient registration, insurance eligibility verification, billing, and clinical workflows, helping healthcare organizations improve operational efficiency and patient experience. Its platform is widely used in outpatient settings, including medical practices and health systems.
Company News
A class action lawsuit has been filed against Phreesia, Inc. alleging securities fraud. The complaint claims the company made false statements about its business prospects while experiencing slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment during the period from May ...
Rosen Law Firm, an investor rights law firm, is notifying shareholders of Microsoft Corporation and other companies about important deadlines for joining securities class action lawsuits. The firm alleges that Microsoft made false statements regarding its Copilot product line's performance issues, competitive positioning, and failure to convert u...
Rosen Law Firm is reminding Phreesia, Inc. investors who purchased stock between May 8, 2025 and March 30, 2026 of the July 13, 2026 deadline to serve as lead plaintiff in a securities class action. The lawsuit alleges that Phreesia made false statements and concealed material facts regarding slowing demand and weakened pharmaceutical marketing c...
Bernstein Liebhard LLP has announced an investigation into whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties to the company. The investigation targets shareholders who purchased shares prior to May 8, 2025. The law firm is seeking affected shareholders to discuss their legal rights and options.
The Schall Law Firm is seeking investors who purchased Phreesia, Inc. securities between May 8, 2025 and March 30, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements regarding its long-term growth outlook and fiscal year 2027 projections, particularly regarding pharmaceutical ...
